|
| 35144966 | Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study. | Clin Cancer Res | 2022 |
| 36527133 | Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study. | Breast Cancer Res | 2022 |
| 35218378 | Is Real-Time Microscopy on the Horizon? A Brief Review of the Potential Future Directions in Clinical Breast Tumor Microscopy Implementation. | Virchows Archiv | 2022 |
| 34376532 | Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma. | Clinical Cancer Research | 2021 |
| 34144976 | CD8<sup>+</sup> T cell immunity blocks the metastasis of carcinogen-exposed breast cancer. | Sci Adv | 2021 |
| 31371343 | <i>FGFR1</i> Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR<sup>+</sup>) Breast Cancer. | Clin Cancer Res | 2019 |
| 30350269 | Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score. | Breast Cancer Res Treat | 2019 |
| 31031007 | Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish. | Cell | 2019 |
| 30911675 | AKT1<sup>low</sup> quiescent cancer cells in ductal carcinoma in situ of the breast. | NPJ Breast Cancer | 2019 |
| 29453314 | AR Expression in Breast Cancer CTCs Associates with Bone Metastases. | Mol Cancer Res | 2018 |
| 29054988 | AKT1<sup>low</sup> Quiescent Cancer Cells Promote Solid Tumor Growth. | Mol Cancer Ther | 2018 |
| 29450494 | Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. | JAMA Oncol | 2018 |
| 29242214 | Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer. | Cancer Discov | 2018 |
| 28096337 | Stress granule-associated protein G3BP2 regulates breast tumor initiation. | Proc Natl Acad Sci U S A | 2017 |
| 28764807 | AKT1<sup>low</sup> quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer. | Breast Cancer Res | 2017 |
| 28939745 | A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR Early-Stage Breast Cancer with One to Three Positive Nodes. | Clinical Cancer Research | 2017 |
| 28485815 | Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing. | Cancer | 2017 |
| 28795152 | Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer. | npj Breast Cancer | 2017 |
| 28252345 | Evidence of stress in β cells obtained with laser capture microdissection from pancreases of brain dead donors. | Islets | 2017 |
| 27551134 | Biomarkers for Early-Stage Breast Cancer: Clinical Utility for Extended Adjuvant Treatment Decisions. | Journal of Clinical Oncology | 2016 |
| 27096583 | CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 12-2016. An 8-Year-Old Boy with an Enlarging Mass in the Right Breast. | New England Journal of Medicine | 2016 |
| 27323815 | The a3 isoform of subunit a of the vacuolar ATPase localizes to the plasma membrane of invasive breast tumor cells and is overexpressed in human breast cancer. | Oncotarget | 2016 |
| 26728744 | Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study. | Breast Cancer Res | 2016 |
| 27252417 | Cross-Stratification and Differential Risk by Breast Cancer Index and Recurrence Score in Women with Hormone Receptor-Positive Lymph Node-Negative Early-Stage Breast Cancer. | Clinical Cancer Research | 2016 |
| 27116182 | Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14. | Breast Cancer Res Treat | 2016 |
| 27758885 | Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation. | Cancer Research | 2016 |
| 27556950 | HER2 expression identifies dynamic functional states within circulating breast cancer cells. | Nature | 2016 |
| 26479444 | Nodes-and-connections RNAi knockdown screening: identification of a signaling molecule network involved in fulvestrant action and breast cancer prognosis. | Oncogenesis | 2015 |
| 25409150 | Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor. | Nature | 2015 |
| 24886537 | VAV3 mediates resistance to breast cancer endocrine therapy. | Breast Cancer Res | 2014 |
| 25489927 | Resolving cancer-stroma interfacial signalling and interventions with micropatterned tumour-stromal assays. | Nature Communications | 2014 |
| 25521819 | Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas. | BMC Medical Genomics | 2014 |
| 25427824 | Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1. | BMC Cancer | 2014 |
| 24346130 | Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS). | Breast Cancer Research and Treatment | 2014 |
| 24715381 | Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer. | Breast Cancer Res Treat | 2014 |
| 24625110 | A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity. | Breast Cancer Res | 2014 |
| 25013076 | Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. | Science | 2014 |
| 23497539 | HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease. | Breast Cancer Research | 2013 |
| 24035531 | Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population. | Lancet Oncology, The | 2013 |
| 23812955 | Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker. | J Natl Cancer Inst | 2013 |
| 23757354 | Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence. | Clinical Cancer Research | 2013 |
| 23755103 | Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A. | PLoS One | 2013 |
| 24131622 | The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials. | Breast Cancer Research | 2013 |
| 23670096 | Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer. | Annals of Oncology | 2013 |
| 23628188 | Planning cancer control in Latin America and the Caribbean. | Lancet Oncol | 2013 |
| 23372014 | Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. | Science | 2013 |
| 21690342 | The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway. | Proceedings of the National Academy of Sciences of the United States of America | 2012 |
| 22722202 | Sequence analysis of mutations and translocations across breast cancer subtypes. | Nature | 2012 |
| 23104009 | Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. | Nat Genet | 2012 |
| 22240506 | Integrated proteomic, transcriptomic, and biological network analysis of breast carcinoma reveals molecular features of tumorigenesis and clinical relapse. | Molecular and Cellular Proteomics | 2012 |